Clinical trial
Minimally Invasive Spleen Preserving Surgery to Treat Primary Splenic Hydatidosis: Short and Long Term Outcomes: A Cohort Study
NCT06289816 is registered in ClinicalTrials.gov with Yarmouk University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimally Invasive Spleen Preserving Surgery to Treat Primary Splenic Hydatidosis: Short and Long Term Outcomes: A Cohort Study
- Lead sponsor
- Yarmouk University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- June 30, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
echinococcus granulosus infection, hydatid disease, minimally invasive surgery, spleen-preserving surgery